Risk of dementia following androgen deprivation therapy for treatment of prostate cancer.

Anna KrasnovaMatthew EpsteinMaya MarcheseBarbra A DickermanAlexander P ColeStuart R LipsitzPaul L NguyenAdam S KibelToni K ChoueiriShehzad BasariaLorelei A MucciMaxine SunQuoc-Dien Trinh

Published in: Prostate cancer and prostatic diseases (2019)

Our study supports an association between pharmacologic ADT and higher risk of all-cause dementia, Alzheimer's, and use of psychiatric services among men with localized and locally advanced PCa.

Keyphrases

prostate cancer
mild cognitive impairment
locally advanced
cognitive impairment
mental health
cognitive decline
squamous cell carcinoma
healthcare
primary care
neoadjuvant chemotherapy
radical prostatectomy
radiation therapy
combination therapy